Latest Conference Articles

Novel Pramlintide & Insulin Combination Therapy Benefits Type 1 Diabetes

Novel Pramlintide & Insulin Combination Therapy Benefits Type 1 Diabetes

March 21st 2021, 7:00pm

Endocrine Society Annual Meeting

A single-injection co-formulation of pramlitide and insulin may be a better alternative to separate administrations of both key treatments in adults with T1D, particularly following meals.

Endocrinology Providers, Patients Express High Satisfaction with Telemedicine

Endocrinology Providers, Patients Express High Satisfaction with Telemedicine

March 21st 2021, 3:00pm

A majority of surveyed patients and providers want to continue telemedicine follow-up visits after the pandemic ends.

Study Identifies Potential Targets for Prevention of Post-MI Heart Failure

Study Identifies Potential Targets for Prevention of Post-MI Heart Failure

March 21st 2021, 1:00pm

Endocrine Society Annual Meeting

Stimulating steroid receptor co-activators may play a role in repairing heart tissue following severe myocardial infarction.

Atypical Thyroid Inflammation Observed in Early COVID-19 Patients

Atypical Thyroid Inflammation Observed in Early COVID-19 Patients

March 20th 2021, 8:32pm

Endocrine Society Annual Meeting

In ENDO 2021 data, approximately one-third of an observed COVID-19 patient population in Italy was still experiencing signs of thyroid inflammation after 3 months,

Liraglutide Shows Promise for Genetic Obesity

Liraglutide Shows Promise for Genetic Obesity

March 20th 2021, 4:00pm

Many patients with genetic obesity disorder experience resistance to treatment, including intensive lifestyle therapy.

Worse Gestational Diabetes Birth Outcomes Associated with Late Nights

Worse Gestational Diabetes Birth Outcomes Associated with Late Nights

March 20th 2021, 3:00pm

Endocrine Society Annual Meeting

Evening and late-night preferences of women with GDM is linked to a significantly greater risk of preeclampsia and NICU treatment.

Higher Doses of Dulaglutide Safe, Efficacious in Patients with Type 2 Diabetes

Higher Doses of Dulaglutide Safe, Efficacious in Patients with Type 2 Diabetes

March 20th 2021, 3:00pm

A post-hoc analysis of the AWARD-11 trial indicates that 4.5 mg of dulaglutide was effective in lowering and maintaining A1C levels <7% regardless of baseline levels.

Edwin Kim, MD, MS: Progressing Food Allergy Research

Edwin Kim, MD, MS: Progressing Food Allergy Research

March 8th 2021, 2:00pm

American Academy of Allergy, Asthma & Immunology

Consideration of how immunotherapy may influence other allergic diseases, patient adherence options, and advancing assessment of peanut allergy options.

Long-term COVID-19 Rehabilitation May Need Improved Systems

Long-term COVID-19 Rehabilitation May Need Improved Systems

March 2nd 2021, 2:00pm

Surveyed patients discharged from the hospital are reporting respiratory burdens beyond 6 months. Are outpatient facilities equipped to manage COVID-19 long haulers?

AAAAI 2021 Research Suggests No Raised Risk of COVID-19 Severity with Asthma

AAAAI 2021 Research Suggests No Raised Risk of COVID-19 Severity with Asthma

March 2nd 2021, 12:00pm

American Academy of Allergy, Asthma & Immunology

A review of 3 new studies, which indicate the association between severe COVID-19 and the chronic disease is more intricate than previously thought.

x